nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Pancytopenia—Doxorubicin—pancreatic cancer	0.000481	0.000481	CcSEcCtD
Dexmethylphenidate—Asthenia—Irinotecan—pancreatic cancer	0.000479	0.000479	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000478	0.000478	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Epirubicin—pancreatic cancer	0.000474	0.000474	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000471	0.000471	CcSEcCtD
Dexmethylphenidate—Dry mouth—Docetaxel—pancreatic cancer	0.000471	0.000471	CcSEcCtD
Dexmethylphenidate—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.00047	0.00047	CcSEcCtD
Dexmethylphenidate—Sweating—Epirubicin—pancreatic cancer	0.000468	0.000468	CcSEcCtD
Dexmethylphenidate—Asthenia—Gemcitabine—pancreatic cancer	0.000466	0.000466	CcSEcCtD
Dexmethylphenidate—Haematuria—Epirubicin—pancreatic cancer	0.000465	0.000465	CcSEcCtD
Dexmethylphenidate—Confusional state—Docetaxel—pancreatic cancer	0.000465	0.000465	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000462	0.000462	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Dexmethylphenidate—Oedema—Docetaxel—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Dexmethylphenidate—Weight increased—Doxorubicin—pancreatic cancer	0.000461	0.000461	CcSEcCtD
Dexmethylphenidate—Epistaxis—Epirubicin—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Dexmethylphenidate—Pruritus—Gemcitabine—pancreatic cancer	0.00046	0.00046	CcSEcCtD
Dexmethylphenidate—Infection—Docetaxel—pancreatic cancer	0.000458	0.000458	CcSEcCtD
Dexmethylphenidate—Weight decreased—Doxorubicin—pancreatic cancer	0.000458	0.000458	CcSEcCtD
Dexmethylphenidate—Sinusitis—Epirubicin—pancreatic cancer	0.000458	0.000458	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Irinotecan—pancreatic cancer	0.000456	0.000456	CcSEcCtD
Dexmethylphenidate—Pneumonia—Doxorubicin—pancreatic cancer	0.000454	0.000454	CcSEcCtD
Dexmethylphenidate—Shock—Docetaxel—pancreatic cancer	0.000454	0.000454	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Dexmethylphenidate—Pruritus—Fluorouracil—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000452	0.000452	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Doxorubicin—pancreatic cancer	0.000451	0.000451	CcSEcCtD
Dexmethylphenidate—Drowsiness—Doxorubicin—pancreatic cancer	0.000451	0.000451	CcSEcCtD
Dexmethylphenidate—Infestation—Doxorubicin—pancreatic cancer	0.000451	0.000451	CcSEcCtD
Dexmethylphenidate—Tachycardia—Docetaxel—pancreatic cancer	0.00045	0.00045	CcSEcCtD
Dexmethylphenidate—Skin disorder—Docetaxel—pancreatic cancer	0.000448	0.000448	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000447	0.000447	CcSEcCtD
Dexmethylphenidate—Bradycardia—Epirubicin—pancreatic cancer	0.000446	0.000446	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000445	0.000445	CcSEcCtD
Dexmethylphenidate—Dizziness—Irinotecan—pancreatic cancer	0.000441	0.000441	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Epirubicin—pancreatic cancer	0.00044	0.00044	CcSEcCtD
Dexmethylphenidate—Anorexia—Docetaxel—pancreatic cancer	0.00044	0.00044	CcSEcCtD
Dexmethylphenidate—Rhinitis—Epirubicin—pancreatic cancer	0.000439	0.000439	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000439	0.000439	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Epirubicin—pancreatic cancer	0.000438	0.000438	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000437	0.000437	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Epirubicin—pancreatic cancer	0.000435	0.000435	CcSEcCtD
Dexmethylphenidate—Sweating—Doxorubicin—pancreatic cancer	0.000433	0.000433	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000432	0.000432	CcSEcCtD
Dexmethylphenidate—Haematuria—Doxorubicin—pancreatic cancer	0.00043	0.00043	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00043	0.00043	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Epirubicin—pancreatic cancer	0.000429	0.000429	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000427	0.000427	CcSEcCtD
Dexmethylphenidate—Epistaxis—Doxorubicin—pancreatic cancer	0.000426	0.000426	CcSEcCtD
Dexmethylphenidate—Vomiting—Irinotecan—pancreatic cancer	0.000424	0.000424	CcSEcCtD
Dexmethylphenidate—Sinusitis—Doxorubicin—pancreatic cancer	0.000423	0.000423	CcSEcCtD
Dexmethylphenidate—Dizziness—Fluorouracil—pancreatic cancer	0.000423	0.000423	CcSEcCtD
Dexmethylphenidate—Visual impairment—Epirubicin—pancreatic cancer	0.000422	0.000422	CcSEcCtD
Dexmethylphenidate—Rash—Irinotecan—pancreatic cancer	0.000421	0.000421	CcSEcCtD
Dexmethylphenidate—Dermatitis—Irinotecan—pancreatic cancer	0.00042	0.00042	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00042	0.00042	CcSEcCtD
Dexmethylphenidate—Headache—Irinotecan—pancreatic cancer	0.000418	0.000418	CcSEcCtD
Dexmethylphenidate—Insomnia—Docetaxel—pancreatic cancer	0.000417	0.000417	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Docetaxel—pancreatic cancer	0.000414	0.000414	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Epirubicin—pancreatic cancer	0.000414	0.000414	CcSEcCtD
Dexmethylphenidate—Vomiting—Gemcitabine—pancreatic cancer	0.000413	0.000413	CcSEcCtD
Dexmethylphenidate—Bradycardia—Doxorubicin—pancreatic cancer	0.000412	0.000412	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Docetaxel—pancreatic cancer	0.000411	0.000411	CcSEcCtD
Dexmethylphenidate—Somnolence—Docetaxel—pancreatic cancer	0.00041	0.00041	CcSEcCtD
Dexmethylphenidate—Rash—Gemcitabine—pancreatic cancer	0.00041	0.00041	CcSEcCtD
Dexmethylphenidate—Dermatitis—Gemcitabine—pancreatic cancer	0.000409	0.000409	CcSEcCtD
Dexmethylphenidate—Eye disorder—Epirubicin—pancreatic cancer	0.000409	0.000409	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000407	0.000407	CcSEcCtD
Dexmethylphenidate—Headache—Gemcitabine—pancreatic cancer	0.000407	0.000407	CcSEcCtD
Dexmethylphenidate—Flushing—Epirubicin—pancreatic cancer	0.000406	0.000406	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Epirubicin—pancreatic cancer	0.000406	0.000406	CcSEcCtD
Dexmethylphenidate—Vomiting—Fluorouracil—pancreatic cancer	0.000406	0.000406	CcSEcCtD
Dexmethylphenidate—Rhinitis—Doxorubicin—pancreatic cancer	0.000406	0.000406	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Docetaxel—pancreatic cancer	0.000406	0.000406	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000405	0.000405	CcSEcCtD
Dexmethylphenidate—Rash—Fluorouracil—pancreatic cancer	0.000403	0.000403	CcSEcCtD
Dexmethylphenidate—Dermatitis—Fluorouracil—pancreatic cancer	0.000403	0.000403	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Doxorubicin—pancreatic cancer	0.000402	0.000402	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Docetaxel—pancreatic cancer	0.000401	0.000401	CcSEcCtD
Dexmethylphenidate—Headache—Fluorouracil—pancreatic cancer	0.0004	0.0004	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.0004	0.0004	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000398	0.000398	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000398	0.000398	CcSEcCtD
Dexmethylphenidate—Fatigue—Docetaxel—pancreatic cancer	0.000398	0.000398	CcSEcCtD
Dexmethylphenidate—Angiopathy—Epirubicin—pancreatic cancer	0.000397	0.000397	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Doxorubicin—pancreatic cancer	0.000397	0.000397	CcSEcCtD
Dexmethylphenidate—Nausea—Irinotecan—pancreatic cancer	0.000396	0.000396	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Epirubicin—pancreatic cancer	0.000395	0.000395	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000395	0.000395	CcSEcCtD
Dexmethylphenidate—Constipation—Docetaxel—pancreatic cancer	0.000394	0.000394	CcSEcCtD
Dexmethylphenidate—Pain—Docetaxel—pancreatic cancer	0.000394	0.000394	CcSEcCtD
Dexmethylphenidate—Chills—Epirubicin—pancreatic cancer	0.000393	0.000393	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Epirubicin—pancreatic cancer	0.000391	0.000391	CcSEcCtD
Dexmethylphenidate—Visual impairment—Doxorubicin—pancreatic cancer	0.00039	0.00039	CcSEcCtD
Dexmethylphenidate—Alopecia—Epirubicin—pancreatic cancer	0.000387	0.000387	CcSEcCtD
Dexmethylphenidate—Nausea—Gemcitabine—pancreatic cancer	0.000386	0.000386	CcSEcCtD
Dexmethylphenidate—Mental disorder—Epirubicin—pancreatic cancer	0.000384	0.000384	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000383	0.000383	CcSEcCtD
Dexmethylphenidate—Malnutrition—Epirubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Dexmethylphenidate—Erythema—Epirubicin—pancreatic cancer	0.000381	0.000381	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Docetaxel—pancreatic cancer	0.00038	0.00038	CcSEcCtD
Dexmethylphenidate—Nausea—Fluorouracil—pancreatic cancer	0.00038	0.00038	CcSEcCtD
Dexmethylphenidate—Eye disorder—Doxorubicin—pancreatic cancer	0.000379	0.000379	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000377	0.000377	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000376	0.000376	CcSEcCtD
Dexmethylphenidate—Flushing—Doxorubicin—pancreatic cancer	0.000376	0.000376	CcSEcCtD
Dexmethylphenidate—Tension—Epirubicin—pancreatic cancer	0.000374	0.000374	CcSEcCtD
Dexmethylphenidate—Nervousness—Epirubicin—pancreatic cancer	0.00037	0.00037	CcSEcCtD
Dexmethylphenidate—Back pain—Epirubicin—pancreatic cancer	0.000369	0.000369	CcSEcCtD
Dexmethylphenidate—Angiopathy—Doxorubicin—pancreatic cancer	0.000368	0.000368	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Epirubicin—pancreatic cancer	0.000366	0.000366	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Doxorubicin—pancreatic cancer	0.000366	0.000366	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000365	0.000365	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Docetaxel—pancreatic cancer	0.000365	0.000365	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Docetaxel—pancreatic cancer	0.000365	0.000365	CcSEcCtD
Dexmethylphenidate—Chills—Doxorubicin—pancreatic cancer	0.000364	0.000364	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Doxorubicin—pancreatic cancer	0.000362	0.000362	CcSEcCtD
Dexmethylphenidate—Vision blurred—Epirubicin—pancreatic cancer	0.000359	0.000359	CcSEcCtD
Dexmethylphenidate—Alopecia—Doxorubicin—pancreatic cancer	0.000358	0.000358	CcSEcCtD
Dexmethylphenidate—Mental disorder—Doxorubicin—pancreatic cancer	0.000355	0.000355	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000354	0.000354	CcSEcCtD
Dexmethylphenidate—Erythema—Doxorubicin—pancreatic cancer	0.000353	0.000353	CcSEcCtD
Dexmethylphenidate—Malnutrition—Doxorubicin—pancreatic cancer	0.000353	0.000353	CcSEcCtD
Dexmethylphenidate—Anaemia—Epirubicin—pancreatic cancer	0.000352	0.000352	CcSEcCtD
Dexmethylphenidate—Agitation—Epirubicin—pancreatic cancer	0.00035	0.00035	CcSEcCtD
Dexmethylphenidate—Tension—Doxorubicin—pancreatic cancer	0.000346	0.000346	CcSEcCtD
Dexmethylphenidate—Malaise—Epirubicin—pancreatic cancer	0.000344	0.000344	CcSEcCtD
Dexmethylphenidate—Nervousness—Doxorubicin—pancreatic cancer	0.000343	0.000343	CcSEcCtD
Dexmethylphenidate—Vertigo—Epirubicin—pancreatic cancer	0.000342	0.000342	CcSEcCtD
Dexmethylphenidate—Syncope—Epirubicin—pancreatic cancer	0.000342	0.000342	CcSEcCtD
Dexmethylphenidate—Leukopenia—Epirubicin—pancreatic cancer	0.000341	0.000341	CcSEcCtD
Dexmethylphenidate—Back pain—Doxorubicin—pancreatic cancer	0.000341	0.000341	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Docetaxel—pancreatic cancer	0.00034	0.00034	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Doxorubicin—pancreatic cancer	0.000339	0.000339	CcSEcCtD
Dexmethylphenidate—Palpitations—Epirubicin—pancreatic cancer	0.000337	0.000337	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Epirubicin—pancreatic cancer	0.000335	0.000335	CcSEcCtD
Dexmethylphenidate—Cough—Epirubicin—pancreatic cancer	0.000333	0.000333	CcSEcCtD
Dexmethylphenidate—Vision blurred—Doxorubicin—pancreatic cancer	0.000332	0.000332	CcSEcCtD
Dexmethylphenidate—Asthenia—Docetaxel—pancreatic cancer	0.000331	0.000331	CcSEcCtD
Dexmethylphenidate—Convulsion—Epirubicin—pancreatic cancer	0.00033	0.00033	CcSEcCtD
Dexmethylphenidate—Hypertension—Epirubicin—pancreatic cancer	0.000329	0.000329	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000327	0.000327	CcSEcCtD
Dexmethylphenidate—Pruritus—Docetaxel—pancreatic cancer	0.000326	0.000326	CcSEcCtD
Dexmethylphenidate—Anaemia—Doxorubicin—pancreatic cancer	0.000326	0.000326	CcSEcCtD
Dexmethylphenidate—Chest pain—Epirubicin—pancreatic cancer	0.000324	0.000324	CcSEcCtD
Dexmethylphenidate—Arthralgia—Epirubicin—pancreatic cancer	0.000324	0.000324	CcSEcCtD
Dexmethylphenidate—Myalgia—Epirubicin—pancreatic cancer	0.000324	0.000324	CcSEcCtD
Dexmethylphenidate—Agitation—Doxorubicin—pancreatic cancer	0.000324	0.000324	CcSEcCtD
Dexmethylphenidate—Anxiety—Epirubicin—pancreatic cancer	0.000323	0.000323	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000322	0.000322	CcSEcCtD
Dexmethylphenidate—Discomfort—Epirubicin—pancreatic cancer	0.000321	0.000321	CcSEcCtD
Dexmethylphenidate—Malaise—Doxorubicin—pancreatic cancer	0.000318	0.000318	CcSEcCtD
Dexmethylphenidate—Dry mouth—Epirubicin—pancreatic cancer	0.000317	0.000317	CcSEcCtD
Dexmethylphenidate—Vertigo—Doxorubicin—pancreatic cancer	0.000317	0.000317	CcSEcCtD
Dexmethylphenidate—Syncope—Doxorubicin—pancreatic cancer	0.000316	0.000316	CcSEcCtD
Dexmethylphenidate—Leukopenia—Doxorubicin—pancreatic cancer	0.000316	0.000316	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Docetaxel—pancreatic cancer	0.000316	0.000316	CcSEcCtD
Dexmethylphenidate—Confusional state—Epirubicin—pancreatic cancer	0.000314	0.000314	CcSEcCtD
Dexmethylphenidate—Palpitations—Doxorubicin—pancreatic cancer	0.000312	0.000312	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000311	0.000311	CcSEcCtD
Dexmethylphenidate—Oedema—Epirubicin—pancreatic cancer	0.000311	0.000311	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00031	0.00031	CcSEcCtD
Dexmethylphenidate—Infection—Epirubicin—pancreatic cancer	0.000309	0.000309	CcSEcCtD
Dexmethylphenidate—Cough—Doxorubicin—pancreatic cancer	0.000308	0.000308	CcSEcCtD
Dexmethylphenidate—Shock—Epirubicin—pancreatic cancer	0.000306	0.000306	CcSEcCtD
Dexmethylphenidate—Convulsion—Doxorubicin—pancreatic cancer	0.000306	0.000306	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000305	0.000305	CcSEcCtD
Dexmethylphenidate—Dizziness—Docetaxel—pancreatic cancer	0.000305	0.000305	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000305	0.000305	CcSEcCtD
Dexmethylphenidate—Hypertension—Doxorubicin—pancreatic cancer	0.000304	0.000304	CcSEcCtD
Dexmethylphenidate—Tachycardia—Epirubicin—pancreatic cancer	0.000304	0.000304	CcSEcCtD
Dexmethylphenidate—Skin disorder—Epirubicin—pancreatic cancer	0.000302	0.000302	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000301	0.000301	CcSEcCtD
Dexmethylphenidate—Arthralgia—Doxorubicin—pancreatic cancer	0.0003	0.0003	CcSEcCtD
Dexmethylphenidate—Chest pain—Doxorubicin—pancreatic cancer	0.0003	0.0003	CcSEcCtD
Dexmethylphenidate—Myalgia—Doxorubicin—pancreatic cancer	0.0003	0.0003	CcSEcCtD
Dexmethylphenidate—Anxiety—Doxorubicin—pancreatic cancer	0.000299	0.000299	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000298	0.000298	CcSEcCtD
Dexmethylphenidate—Discomfort—Doxorubicin—pancreatic cancer	0.000297	0.000297	CcSEcCtD
Dexmethylphenidate—Anorexia—Epirubicin—pancreatic cancer	0.000297	0.000297	CcSEcCtD
Dexmethylphenidate—Dry mouth—Doxorubicin—pancreatic cancer	0.000294	0.000294	CcSEcCtD
Dexmethylphenidate—Vomiting—Docetaxel—pancreatic cancer	0.000293	0.000293	CcSEcCtD
Dexmethylphenidate—Rash—Docetaxel—pancreatic cancer	0.000291	0.000291	CcSEcCtD
Dexmethylphenidate—Dermatitis—Docetaxel—pancreatic cancer	0.000291	0.000291	CcSEcCtD
Dexmethylphenidate—Confusional state—Doxorubicin—pancreatic cancer	0.00029	0.00029	CcSEcCtD
Dexmethylphenidate—Headache—Docetaxel—pancreatic cancer	0.000289	0.000289	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000288	0.000288	CcSEcCtD
Dexmethylphenidate—Oedema—Doxorubicin—pancreatic cancer	0.000288	0.000288	CcSEcCtD
Dexmethylphenidate—Infection—Doxorubicin—pancreatic cancer	0.000286	0.000286	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000283	0.000283	CcSEcCtD
Dexmethylphenidate—Shock—Doxorubicin—pancreatic cancer	0.000283	0.000283	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000282	0.000282	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000282	0.000282	CcSEcCtD
Dexmethylphenidate—Insomnia—Epirubicin—pancreatic cancer	0.000281	0.000281	CcSEcCtD
Dexmethylphenidate—Tachycardia—Doxorubicin—pancreatic cancer	0.000281	0.000281	CcSEcCtD
Dexmethylphenidate—Skin disorder—Doxorubicin—pancreatic cancer	0.00028	0.00028	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Epirubicin—pancreatic cancer	0.000279	0.000279	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000278	0.000278	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Epirubicin—pancreatic cancer	0.000277	0.000277	CcSEcCtD
Dexmethylphenidate—Somnolence—Epirubicin—pancreatic cancer	0.000277	0.000277	CcSEcCtD
Dexmethylphenidate—Anorexia—Doxorubicin—pancreatic cancer	0.000274	0.000274	CcSEcCtD
Dexmethylphenidate—Nausea—Docetaxel—pancreatic cancer	0.000274	0.000274	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Epirubicin—pancreatic cancer	0.000274	0.000274	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Epirubicin—pancreatic cancer	0.00027	0.00027	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000269	0.000269	CcSEcCtD
Dexmethylphenidate—Fatigue—Epirubicin—pancreatic cancer	0.000268	0.000268	CcSEcCtD
Dexmethylphenidate—Pain—Epirubicin—pancreatic cancer	0.000266	0.000266	CcSEcCtD
Dexmethylphenidate—Constipation—Epirubicin—pancreatic cancer	0.000266	0.000266	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000262	0.000262	CcSEcCtD
Dexmethylphenidate—Insomnia—Doxorubicin—pancreatic cancer	0.00026	0.00026	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Doxorubicin—pancreatic cancer	0.000258	0.000258	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Doxorubicin—pancreatic cancer	0.000257	0.000257	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000256	0.000256	CcSEcCtD
Dexmethylphenidate—Somnolence—Doxorubicin—pancreatic cancer	0.000256	0.000256	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000254	0.000254	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000253	0.000253	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Doxorubicin—pancreatic cancer	0.00025	0.00025	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000248	0.000248	CcSEcCtD
Dexmethylphenidate—Fatigue—Doxorubicin—pancreatic cancer	0.000248	0.000248	CcSEcCtD
Dexmethylphenidate—Urticaria—Epirubicin—pancreatic cancer	0.000247	0.000247	CcSEcCtD
Dexmethylphenidate—Pain—Doxorubicin—pancreatic cancer	0.000246	0.000246	CcSEcCtD
Dexmethylphenidate—Constipation—Doxorubicin—pancreatic cancer	0.000246	0.000246	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Epirubicin—pancreatic cancer	0.000246	0.000246	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Epirubicin—pancreatic cancer	0.000246	0.000246	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000237	0.000237	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000235	0.000235	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000229	0.000229	CcSEcCtD
Dexmethylphenidate—Urticaria—Doxorubicin—pancreatic cancer	0.000229	0.000229	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000228	0.000228	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000228	0.000228	CcSEcCtD
Dexmethylphenidate—Asthenia—Epirubicin—pancreatic cancer	0.000223	0.000223	CcSEcCtD
Dexmethylphenidate—Pruritus—Epirubicin—pancreatic cancer	0.00022	0.00022	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Epirubicin—pancreatic cancer	0.000213	0.000213	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000212	0.000212	CcSEcCtD
Dexmethylphenidate—Asthenia—Doxorubicin—pancreatic cancer	0.000207	0.000207	CcSEcCtD
Dexmethylphenidate—Dizziness—Epirubicin—pancreatic cancer	0.000206	0.000206	CcSEcCtD
Dexmethylphenidate—Pruritus—Doxorubicin—pancreatic cancer	0.000204	0.000204	CcSEcCtD
Dexmethylphenidate—Vomiting—Epirubicin—pancreatic cancer	0.000198	0.000198	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000197	0.000197	CcSEcCtD
Dexmethylphenidate—Rash—Epirubicin—pancreatic cancer	0.000196	0.000196	CcSEcCtD
Dexmethylphenidate—Dermatitis—Epirubicin—pancreatic cancer	0.000196	0.000196	CcSEcCtD
Dexmethylphenidate—Headache—Epirubicin—pancreatic cancer	0.000195	0.000195	CcSEcCtD
Dexmethylphenidate—Dizziness—Doxorubicin—pancreatic cancer	0.00019	0.00019	CcSEcCtD
Dexmethylphenidate—Nausea—Epirubicin—pancreatic cancer	0.000185	0.000185	CcSEcCtD
Dexmethylphenidate—Vomiting—Doxorubicin—pancreatic cancer	0.000183	0.000183	CcSEcCtD
Dexmethylphenidate—Rash—Doxorubicin—pancreatic cancer	0.000181	0.000181	CcSEcCtD
Dexmethylphenidate—Dermatitis—Doxorubicin—pancreatic cancer	0.000181	0.000181	CcSEcCtD
Dexmethylphenidate—Headache—Doxorubicin—pancreatic cancer	0.00018	0.00018	CcSEcCtD
Dexmethylphenidate—Nausea—Doxorubicin—pancreatic cancer	0.000171	0.000171	CcSEcCtD
